海外の治験の状況「前立腺癌」での検索結果
107件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent
- Prostate Cancer Metastatic
- Austria, Belgium, Czechia, France, Germany, Greece, Iceland, Ireland, Italy, Netherlands, Norway, Spain, United Kingdom
- 2015-06-26
Not Recruiting
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Estonia, France, Germany, Greece, India, Israel, Italy, Korea, Republic of, Latvia, Lebanon, Lithuania, Mexico, Netherlands, New Zealand, Panama, Peru, Poland, Romania, Russian Federation, Slovakia, Spain, Sweden, Taiwan, Province of China, Turkey, Ukraine, United Kingdom, United States
- 2015-04-30
Not Recruiting
- A MULTINATIONAL, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III EFFICACY AND SAFETY STUDY OF ODM-201 IN MEN WITH HIGH-RISK NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
- -C61 Malignant neoplasm of prostate Malignant neoplasm of prostate;Malignant neoplasm of prostate
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, China, Czech Republic, Finland, France, Germany, Greece, Hungary, Israel, Italy, Korea South, Latvia, Netherlands, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Switzerland, Taiwan, Turkey, Ukraine, United Kindgdom, United States
- 2015-04-29
Not recruiting
- Efficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Nonmetastatic Castration-resistant Prostate Cancer
- Prostate Cancer Non-Metastatic;Castration-Resistant
- Argentina, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, Colombia, Czech Republic, Czechia, Estonia, Finland, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Peru, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, South Africa, Spain, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, United States
- 2014-07-22
Not Recruiting
- A clinical trial for advanced prostatic cancer patients . The study medication will be Leuprolide Mesylate, which will be administered as an injection twice. Both the study doctors and clinical trial participants know which treatment is being administered, there will be only one treatment group. The safety and efficacy of the medicinal product will be tested during the study.
- Advanced Prostate Carcinoma MedDRA version: 19.0 Level: LLT Classification code 10036921 Term: Prostate carcinoma System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Austria, Czech Republic, Germany, Lithuania, Poland, Slovakia, Taiwan, United States
- 2014-06-25
Not recruiting
- Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: ENZAMET
- Prostate Cancer
- Australia, Canada, Ireland, New Zealand, United Kingdom, United States of America
- 2014-01-29
Not recruiting
- A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)
- Prostate Neoplasms
- Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Czech Republic, Czechia, Denmark, Finland, France, Germany, Hungary, Israel, Japan, Korea, Republic of, Malaysia, Mexico, Netherlands, New Zealand, Peru, Poland, Portugal, Romania, Russian Federation, Singapore, Slovakia, South Africa, Spain, Sweden, Turkey, Ukraine, United Kingdom
- 2012-10-24
Not Recruiting
- Prospective-randomized and double-blinded trial to evaluate the impact of a peritoneal flap on outcome and postoperative complications after robotic assisted radical prostatectomy (RARP) in patients with localized prostate cancer
- ;C61 - Malignant neoplasm of prostate;I89.8 - Other specified noninfective disorders of lymphatic vessels and lymph nodes
- Austria, Germany
- 2016-12-08
Not recruiting
- Study of Olaparib (Lynparza™) Versus Enzalutamide or Abiraterone Acetate in Men With Metastatic Castration-Resistant Prostate Cancer (PROfound Study)
- Metastatic Castration-resistant Prostate Cancer
- Argentina, Australia, Austria, Brazil, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Norway, Spain, Sweden, Taiwan, Turkey, United Kingdom, United States
- 2016-11-15
Not Recruiting
- A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone With or Without Lenalidomide in Subjects With Castrate-Resistant Prostate Cancer (CRPC)
- Prostate Cancer;C61 - Malignant neoplasm of prostate
- Australia, Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Greece, Hungary, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, South Africa, Spain, Sweden, United Kingdom, United States
- 2012-04-30